8 regulation of miscellaneous products Flashcards
what is the summary of this lecture?
-veterinary pharmaceuticals
-natural health products
-cosmetics
-medical devices
-novel foods
-food additives
what is the evidence needed for veterinary pharmaceuticals?
a veterinary drug is approved for sale in Canada is the manufacturer has supplied evidence that the drug:
-is safe for the animals being treated
-is effective treating the condition for which it is marketed
-is manufactured according to strict specifications
-will not pose demonstrable health hazard to humans eating food products from treated animals
what are the regulatory agencies of veterinary pharmaceuticals?
Veterinary Drugs Directorate (VDD), Health Canada
-food and drugs act and regulations
what is extra-label drug use (ELDU) in animals (“off-label use”)?
-the use or intended use of a drug approved by Health Canada in an animal in a manner not in accordance with the label or package insert
-it also includes the use of all unapproved drugs, including unapproved bulk active pharmaceutical ingredients (APIs) and compounded drugs
-VDD acknowledges that ELDU is an important tool in the practice of veterinary medicine
what are the decisions to use ELDU?
-a potential lack of efficacy of approved products
-lack of approved products to address specific needs
-economic considerations
what are the possible human health risks relating to ELDU in animals?
-development of antimicrobial resistance (AMR)
-presence of drug residue in foods derived from treated animals and in the environment
what is antimicrobial resistance (AMR)?
-antimicrobials are the most effective treatment for infectious diseases
-AMR is a natural microbial survival mechanism; however, the overuse and misuses of antimicrobials has increased the rate of resistance development and spread
-many available antimicrobials are now less effective for treating disease
-AMR is an emerging global health issue
how many people in canada have AMR?
-there has been an 8-fold increase in the rate of methicillin resistance Staphylococcus aureus (MRSA) infections among hospitalized patients in canada from 1995-2012
-each year in canada, more than 18,000 hospitalized patients acquire infections that are resistant to antimicrobials
what are the categories of antimicrobials?
-the antimicrobials in Category 1: essential for the treatment of serious bacterial infections and there are limited or no availability of alternative antimicrobials in case of resistance to these antimicrobials
-Health Canada is recommending against Category 1 antimicrobials use in an ELDU manner
what are maximum residue limits (MRLs)?
-level of residue that could safely remain in the tissue or food product derived from a food-producing animal that has been treated with a veterinary drug
-no adverse health effects if ingested daily by humans over a lifetime
-veterinary Drugs Directorate (HC) conducts extensive reviews of data submitted by manufacturers to determine whether these veterinary drug residues are at safe levels for human consumption
what is the list of MRLs for veterinary drugs in foods?
what does it mean when there is no MRL required?
-low toxicity drug, poorly absorbed or bioavailable, rapidly metabolized or eliminated, likely infrequently used, etc
-no need to routinely monitor the residues of these veterinary drugs in specific foods
what is the health risk assessment process to establish MRLs?
metabolism studies of veterinary drugs conducted in the food-producing animals (e.g. swine, chickens, cows, etc) are reviewed
-concentration and half-life of a drug and its metabolites
comparative metabolism studies conducted in laboratory test animals are reviewed
-similar metabolism pattern?
toxicity of the substance is determined by toxicity/carcinogenicity (cancer) testing
-used to determine Acceptable Daily Intake (ADI)
what else is involved in the health risk assessment process to establish MRLs?
-a marker residue is identified for the purpose of drug analysis, and an analytical method is developed
-withdrawal period: residue depletion data for the marker residue in the target tissue (highest concentration)
what are do the labels contain on veterinary drugs (MRLs)?
-must include WARNING statements that highlight the human safety related issues on its use
-withdrawal periods for tissues or withholding times for milk
-in a food producing animal, the specified withdrawal period of the withholding time must be observed before the animal is slaughtered or the milk is harvested for use as food to allow the residues to deplete below the MRL